Beyond Air (XAIR) Net Equity Issued and Repurchased (2017 - 2026)

Beyond Air (XAIR) reported Net Equity Issued and Repurchased of $3.8 million for Q1 2026, down 79.19% on a YoY basis from $18.3 million in Q1 2025, and up 442.86% sequentially from $700000.0 in Q4 2025.

Beyond Air (XAIR) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends

Beyond Air (XAIR) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $3.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Equity Issued and Repurchased fell 79.19% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 65.87% YoY), and the FY2026 full-year result was $4.5 million, down 76.14% from the prior year.
  • Net Equity Issued and Repurchased improved to $3.8 million in Q1 2026, from $700000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $18.3 million in Q1 2025 to a low of -$18.3 million in Q4 2024.
  • A 5-year average of $2.4 million and a median of $3.5 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • Across the five-year window, Net Equity Issued and Repurchased tumbled 2715.42% in 2023 and jumped 278.17% in 2024, its largest moves.
  • Tracing XAIR's Net Equity Issued and Repurchased over 5 years: stood at $214000.0 in 2022, then plunged by 2715.42% to -$5.6 million in 2023, then plunged by 226.21% to -$18.3 million in 2024, then surged by 103.83% to $700000.0 in 2025, then jumped by 442.86% to $3.8 million in 2026.
  • Business Quant data shows XAIR's Net Equity Issued and Repurchased at $3.8 million in Q1 2026, $700000.0 in Q4 2025, and $18.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Beyond Air 2.25 Mn -10.02 Mn 94,000.00 3.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.80 Mn
Mar 31, 2026 3.80 Mn
Dec 31, 2025 700,000.00
Dec 31, 2025 700,000.00
Mar 31, 2025 18.26 Mn
Mar 31, 2025 18.26 Mn
Dec 31, 2024 -18.26 Mn
Dec 31, 2024 -18.26 Mn
Mar 31, 2024 13.18 Mn
Mar 31, 2024 13.18 Mn
Sep 30, 2023 -5.60 Mn
Sep 30, 2023 -5.60 Mn
Jun 30, 2023 5.81 Mn
Jun 30, 2023 5.81 Mn
Mar 31, 2023 3.49 Mn
Mar 31, 2023 3.49 Mn
Sep 30, 2022 214,000.00
Sep 30, 2022 214,000.00
Dec 31, 2021 10.10 Mn
Dec 31, 2021 10.10 Mn